Keywords: ista, debut, xibrom, 2nd-qtr, food, drug, administration
ISTA to debut Xibrom in 2nd-qtr 2005
Article | 04 April 2005
The US Food and Drug Administration has cleared ISTA Pharmaceuticals' New Drug Application for its non-steroidal anti-inflammatory drug Xibrom (bromfenac ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
